(2R)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-4-pentynoic acid is a non-natural, chiral amino acid derivative. Its structure features an Fmoc-protected amino group, a carboxylic acid group, and a terminal alkyne moiety attached to a quaternary α-carbon center. This combination of functional groups makes it a valuable building block in synthetic chemistry. The primary application of this compound is in the field of peptide and peptidomimetic synthesis, particularly in solid-phase peptide synthesis (SPPS). The Fmoc group serves as a standard, base-labile protecting group for the amino functionality during peptide chain assembly. The terminal alkyne group provides a versatile handle for post-synthetic modifications via click chemistry, such as the copper-catalyzed azide-alkyne cycloaddition (CuAAC). This allows for the site-specific conjugation of peptides to various labels, polymers, or surfaces, or for the synthesis of cyclic or constrained peptides. The quaternary α-carbon introduces steric hindrance and conformational constraints, which can be used to modulate the biological activity and metabolic stability of the resulting peptide analogs. As a specialized, non-proteinogenic amino acid derivative, it is not considered a generic organic synthesis building block. Its design and utility are highly targeted towards advanced medicinal chemistry and chemical biology research for developing novel therapeutic agents and bioconjugates.